25816-30-2Relevant academic research and scientific papers
NOVEL TRIAZINE COMPOUNDS
-
Page/Page column 141, (2014/02/16)
The present invention relates to novel triazine compounds of formula (1). The present invention also discloses compounds of formula I along with other pharmaceutical ac-ceptable excipients and use of the compounds to modulate the PI3K/ mTOR pathway
TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS
-
Page/Page column 119, (2010/12/29)
The present invention comprises inter alia compounds as shown in formula (I) or a pharmaceutically acceptable salt thereof.
HETEROARYL SUBSTITUTED PYROLLS USEFUL AS INHIBITORS OF PROTEIN KINASES
-
Page 33, (2008/06/13)
The present invention provides compounds that are inhibitors of protein kinase, particularly inhibitors of ERK2, GSK3, PKA, CDK2 protein kinases, mammalian protein kinases involved in proliferative and neurodegenerative disorders. The invention also provi
Kinase inhibitors
-
Page/Page column 221, (2010/02/07)
The invention relates to inhibitors of enzymes that bind to ATP or GTP and/or catalyze phosphoryl transfer, compositions comprising the inhibitors, and methods of using the inhibitors and inhibitor compositions. The inhibitors and compositions comprising them are useful for treating disease or disease symptoms. The invention also provides for methods of making phosphoryl transferase inhibitor compounds, methods of inhibiting phosphoryl transferase activity, and methods for treating disease or disease symptoms.
